🇺🇸 FDA
Patent

US 10883994

Identification of cancer stem cells markers and use of same for diagnosis and treatment

granted A61KA61K31/275A61P

Quick answer

US patent 10883994 (Identification of cancer stem cells markers and use of same for diagnosis and treatment) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/275, A61P, A61P35/00